520 related articles for article (PubMed ID: 31088334)
21. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment.
Hoermann R; Midgley JE; Giacobino A; Eckl WA; Wahl HG; Dietrich JW; Larisch R
Clin Endocrinol (Oxf); 2014 Dec; 81(6):907-15. PubMed ID: 24953754
[TBL] [Abstract][Full Text] [Related]
22. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
[TBL] [Abstract][Full Text] [Related]
23. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
24. Association of metabolic syndrome parameters with TT3 and FT3/FT4 ratio in obese Turkish population.
Tarcin O; Abanonu GB; Yazici D; Tarcin O
Metab Syndr Relat Disord; 2012 Apr; 10(2):137-42. PubMed ID: 22229843
[TBL] [Abstract][Full Text] [Related]
25. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement.
al-Adsani H; Hoffer LJ; Silva JE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1118-25. PubMed ID: 9100583
[TBL] [Abstract][Full Text] [Related]
26. Short-term Change in Resting Energy Expenditure and Body Compositions in Therapeutic Process for Graves' Disease.
Hayashi A; Takano K; Kawakami Y; Hitomi M; Ohata Y; Suzuki A; Kamata Y; Shichiri M
Intern Med; 2020; 59(15):1827-1833. PubMed ID: 32741892
[TBL] [Abstract][Full Text] [Related]
27. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
28. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
[TBL] [Abstract][Full Text] [Related]
29. The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity.
Marzullo P; Minocci A; Mele C; Fessehatsion R; Tagliaferri M; Pagano L; Scacchi M; Aimaretti G; Sartorio A
PLoS One; 2018; 13(10):e0205293. PubMed ID: 30339686
[TBL] [Abstract][Full Text] [Related]
30. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
[TBL] [Abstract][Full Text] [Related]
31. Recombinant Human Thyrotropin Worsens Renal Cortical Perfusion and Renal Function in Patients After Total Thyroidectomy Due to Differentiated Thyroid Cancer.
Saracyn M; Lubas A; Bober B; Kowalski Ł; Kapusta W; Niemczyk S; Wartofsky L; Kamiński G
Thyroid; 2020 May; 30(5):653-660. PubMed ID: 31964314
[No Abstract] [Full Text] [Related]
32. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
33. Associations between subclinical thyroid disease and metabolic syndrome.
Wang CY; Chang TC; Chen MF
Endocr J; 2012; 59(10):911-7. PubMed ID: 22785370
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the relationship between subclinical hypothyroidism and metabolic syndrome components among workers.
Cheserek MJ; Wu G; Shen L; Shi Y; Le G
Int J Occup Med Environ Health; 2014 Apr; 27(2):175-87. PubMed ID: 24619737
[TBL] [Abstract][Full Text] [Related]
35. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
36. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects.
Pinkney JH; Goodrick SJ; Katz J; Johnson AB; Lightman SL; Coppack SW; Mohamed-Ali V
Clin Endocrinol (Oxf); 1998 Nov; 49(5):583-8. PubMed ID: 10197072
[TBL] [Abstract][Full Text] [Related]
37. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
[TBL] [Abstract][Full Text] [Related]
38. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema.
Karmisholt J; Andersen S; Laurberg P
J Clin Endocrinol Metab; 2011 Jan; 96(1):E99-103. PubMed ID: 20926526
[TBL] [Abstract][Full Text] [Related]
39. The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.
Verburg FA; Mäder U; Grelle I; Visser TJ; Peeters RP; Smit JW; Reiners C
Horm Metab Res; 2014 Oct; 46(11):794-9. PubMed ID: 24867137
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
